Exact Mass: 1284.6707366

Exact Mass Matches: 1284.6707366

Found 15 metabolites which its exact mass value is equals to given mass value 1284.6707366, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

11-oxo Mogroside V

11-oxo-mogroside V

C60H100O29 (1284.635)


11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively. 11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively.

   

11-Oxomogroside

11-oxo-mogroside V

C60H100O29 (1284.635)


11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively. 11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively.

   

11-oxo-mogroside V

11-oxo-mogroside V

C60H100O29 (1284.635)


11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively. 11-oxo-mogroside V is a natural sweetener that exhibits strong antioxidant activity. It exhibits significant inhibitory effects on reactive oxygen species (O2-, H2O2 and *OH) with EC50 of 4.79, 16.52, and 146.17 μg/mL, respectively.

   

3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl saniculagenin C 28-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|sorbifoliaside A

3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl saniculagenin C 28-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|sorbifoliaside A

C60H100O29 (1284.635)


   

3-O-beta-D-glucopyranosyl(1?6)-[beta-D-glucopyranosyl(1?2)]-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)-beta-D-glucopyranosyl 16-deoxybarringtogenol C|xanthohuskiside B

3-O-beta-D-glucopyranosyl(1?6)-[beta-D-glucopyranosyl(1?2)]-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)-beta-D-glucopyranosyl 16-deoxybarringtogenol C|xanthohuskiside B

C60H100O29 (1284.635)


   
   
   

dicyanocobyrinic acid heptapropyl ester

dicyanocobyrinic acid heptapropyl ester

C68H101CoN6O14 (1284.6707)


   

TAK-448 (acetate)

TAK-448 (acetate)

C60H84N16O16 (1284.6251)


TAK-448 acetate (MVT-602 acetate) is a potent and full KISS1R agonist with an IC50 of 460 pM and an EC50 of 632 pM[1].

   

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2r,5r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-hydroxy-6-methylheptan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2r,5r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-hydroxy-6-methylheptan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C60H100O29 (1284.635)


   

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2s,5r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-hydroxy-6-methylheptan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2s,5r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-hydroxy-6-methylheptan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C60H100O29 (1284.635)


   

11-oxo-mogroside v

NA

C60H100O29 (1284.635)


{"Ingredient_id": "HBIN000514","Ingredient_name": "11-oxo-mogroside v","Alias": "NA","Ingredient_formula": "C60H100O29","Ingredient_Smile": "CC(CCC(C(C)(C)O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)C4CCC5(C4(CC(=O)C6(C5CC=C7C6CCC(C7(C)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)C)C)C","Ingredient_weight": "1285.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "15838","PubChem_id": "137705355","DrugBank_id": "NA"}

   

(2s,3r,4r,5s,6s)-5-{[(2s,3r,4s,5s,6s)-3-hydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]-4-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-2-yl]oxy}-6-methyl-2-{[(1r,3s,5s,6r,7r,8r,20s,22r,24r,25s,26s)-7,25,26-trihydroxy-24-(hydroxymethyl)-5-methyl-10-oxo-20-pentyl-2,4,9,21,23-pentaoxatricyclo[20.4.0.0³,⁸]hexacosan-6-yl]oxy}-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl (2s)-2-methylbutanoate

(2s,3r,4r,5s,6s)-5-{[(2s,3r,4s,5s,6s)-3-hydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]-4-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-2-yl]oxy}-6-methyl-2-{[(1r,3s,5s,6r,7r,8r,20s,22r,24r,25s,26s)-7,25,26-trihydroxy-24-(hydroxymethyl)-5-methyl-10-oxo-20-pentyl-2,4,9,21,23-pentaoxatricyclo[20.4.0.0³,⁸]hexacosan-6-yl]oxy}-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl (2s)-2-methylbutanoate

C64H100O26 (1284.6503)


   

1-{5-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl)oxy]-6-hydroxy-6-methylheptan-2-yl}-3a,6,6,9b,11a-pentamethyl-7-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

1-{5-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl)oxy]-6-hydroxy-6-methylheptan-2-yl}-3a,6,6,9b,11a-pentamethyl-7-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C60H100O29 (1284.635)


   

5-({3-hydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]-4-[(3-phenylprop-2-enoyl)oxy]oxan-2-yl}oxy)-6-methyl-2-{[7,25,26-trihydroxy-24-(hydroxymethyl)-5-methyl-10-oxo-20-pentyl-2,4,9,21,23-pentaoxatricyclo[20.4.0.0³,⁸]hexacosan-6-yl]oxy}-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl 2-methylbutanoate

5-({3-hydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]-4-[(3-phenylprop-2-enoyl)oxy]oxan-2-yl}oxy)-6-methyl-2-{[7,25,26-trihydroxy-24-(hydroxymethyl)-5-methyl-10-oxo-20-pentyl-2,4,9,21,23-pentaoxatricyclo[20.4.0.0³,⁸]hexacosan-6-yl]oxy}-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl 2-methylbutanoate

C64H100O26 (1284.6503)